scholarly journals Nephropathic Cystinosis: Pathogenic Roles of Inflammation and Potential for New Therapies

Cells ◽  
2022 ◽  
Vol 11 (2) ◽  
pp. 190
Author(s):  
Mohamed A. Elmonem ◽  
Koenraad R. P. Veys ◽  
Giusi Prencipe

The activation of several inflammatory pathways has recently been documented in patients and different cellular and animal models of nephropathic cystinosis. Upregulated inflammatory signals interact with many pathogenic aspects of the disease, such as enhanced oxidative stress, abnormal autophagy, inflammatory cell recruitment, enhanced cell death, and tissue fibrosis. Cysteamine, the only approved specific therapy for cystinosis, ameliorates many but not all pathogenic aspects of the disease. In the current review, we summarize the inflammatory mechanisms involved in cystinosis and their potential impact on the disease pathogenesis and progression. We further elaborate on the crosstalk between inflammation, autophagy, and apoptosis, and discuss the potential of experimental drugs for suppressing the inflammatory signals in cystinosis.

PLoS ONE ◽  
2015 ◽  
Vol 10 (12) ◽  
pp. e0145147 ◽  
Author(s):  
Silvia Affò ◽  
Daniel Rodrigo-Torres ◽  
Delia Blaya ◽  
Oriol Morales-Ibanez ◽  
Mar Coll ◽  
...  

2015 ◽  
Vol 59 (10) ◽  
pp. 6317-6327 ◽  
Author(s):  
Hussein Traboulsi ◽  
Alexandre Cloutier ◽  
Kumaraswamy Boyapelly ◽  
Marc-André Bonin ◽  
Éric Marsault ◽  
...  

ABSTRACTThe host response to influenza virus infection is characterized by an acute lung inflammatory response in which intense inflammatory cell recruitment, hypercytokinemia, and a high level of oxidative stress are present. The sum of these events contributes to the virus-induced lung damage that leads to high a level of morbidity and mortality in susceptible infected patients. In this context, we identified compounds that can simultaneously reduce the excessive inflammatory response and the viral replication as a strategy to treat influenza virus infection. We investigated the anti-inflammatory and antiviral potential activities of isoliquiritigenin (ILG). Interestingly, we demonstrated that ILG is a potent inhibitor of influenza virus replication in human bronchial epithelial cells (50% effective concentration [EC50] = 24.7 μM). In addition, our results showed that this molecule inhibits the expression of inflammatory cytokines induced after the infection of cells with influenza virus. We demonstrated that the anti-inflammatory activity of ILG in the context of influenza virus infection is dependent on the activation of the peroxisome proliferator-activated receptor gamma pathway. Interestingly, ILG phosphate (ILG-p)-treated mice displayed decreased lung inflammation as depicted by reduced cytokine gene expression and inflammatory cell recruitment. We also demonstrated that influenza virus-specific CD8+effector T cell recruitment was reduced up to 60% in the lungs of mice treated with ILG-p (10 mg/kg) compared to that in saline-treated mice. Finally, we showed that administration of ILG-p reduced lung viral titers and morbidity of mice infected with the PR8/H1N1 virus.


2007 ◽  
Vol 26 (4) ◽  
pp. 1129-1139 ◽  
Author(s):  
Valeria V Orlova ◽  
Eun Young Choi ◽  
Changping Xie ◽  
Emmanouil Chavakis ◽  
Angelika Bierhaus ◽  
...  

2012 ◽  
Vol 130 (4) ◽  
pp. 869-876.e2 ◽  
Author(s):  
Michelle L. Hernandez ◽  
Margaret Herbst ◽  
John C. Lay ◽  
Neil E. Alexis ◽  
Willie June Brickey ◽  
...  

2010 ◽  
Vol 88 (1) ◽  
pp. 159-167 ◽  
Author(s):  
Sara J. McSweeney ◽  
Patrick W.F. Hadoke ◽  
Agnieszka M. Kozak ◽  
Gary R. Small ◽  
Hiba Khaled ◽  
...  

2020 ◽  
Vol 22 (5) ◽  
pp. 1324-1332
Author(s):  
Marie-Aline Neveu ◽  
Nicolas Beziere ◽  
Rolf Daniels ◽  
Caroline Bouzin ◽  
Arnaud Comment ◽  
...  

Abstract Purpose Inflammation is involved in many disease processes. However, accurate imaging tools permitting diagnosis and characterization of inflammation are still missing. As inflamed tissues exhibit a high rate of glycolysis, pyruvate metabolism may offer a unique approach to follow the inflammatory response and disease progression. Therefore, the aim of the study was to follow metabolic changes and recruitment of inflammatory cells after onset of inflammation in arthritic ankles using hyperpolarized 1-13C-pyruvate magnetic resonance spectroscopy (MRS) and 19F magnetic resonance imaging (MRI), respectively. Procedure Experimental rheumatoid arthritis (RA) was induced by intraperitoneal injection of glucose-6-phosphate-isomerase-specific antibodies (GPI) containing serum. To monitor pyruvate metabolism, the transformation of hyperpolarized 1-13C-pyruvate into hyperpolarized 1-13C-lactate was followed using MRS. To track phagocytic immune cell homing, we intravenously injected a perfluorocarbon emulsion 48 h before imaging. The animals were scanned at days 1, 3, or 6 after GPI-serum injection to examine the different stages of arthritic inflammation. Finally, to confirm the pyruvate metabolic activity and the link to inflammatory cell recruitment, we conducted hematoxylin-eosin histopathology and monocarboxylase transporter (MCT-1) immune histochemistry (IHC) of inflamed ankles. Results Hyperpolarized 1-13C-pyruvate MRS revealed a high rate of lactate production immediately at day 1 after GPI-serum transfer, which remained elevated during the progression of the disease, while 19F-MRI exhibited a gradual recruitment of phagocytic immune cells in arthritic ankles, which correlated well with the course of ankle swelling. Histopathology and IHC revealed that MCT-1 was expressed in regions with inflammatory cell recruitment, confirming the metabolic shift identified in arthritic ankles. Conclusions Our study demonstrated the presence of a very early metabolic shift in arthritic joints independent of phagocytic immune cell recruitment. Thus, hyperpolarized 1-13C-pyruvate represents a promising tracer to monitor acute arthritic joint inflammation, even with minor ankle swelling. Furthermore, translated to the clinics, these methods add a detailed characterization of disease status and could substantially support patient stratification and therapy monitoring.


2008 ◽  
Vol 181 (2) ◽  
pp. 1409-1419 ◽  
Author(s):  
Gloria S. Pryhuber ◽  
Heidie L. Huyck ◽  
Samir Bhagwat ◽  
Michael A. O'Reilly ◽  
Jacob N. Finkelstein ◽  
...  

2001 ◽  
Vol 421 (3) ◽  
pp. 201-205 ◽  
Author(s):  
Soazig Nénan ◽  
Noëlla Germain ◽  
Vincent Lagente ◽  
Xavier Emonds-Alt ◽  
Charles Advenier ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document